Skip to content

EPS (Diluted) at other companies

Travel + Leisure logo
Travel + LeisureTNL
$1.22+14.0%
Warrior Met Coal logo
Warrior Met CoalHCC
$1.37+956%
Cabot Corporation logo
Cabot CorporationCBT
$1.27-24.9%
Unifirst logo
UnifirstUNF
$1.13-13.7%
Main Street Capital logo
Main Street CapitalMAIN
$0.93-4.1%
MYR Group logo
MYR GroupMYRG
$2.99+106%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Operating income$477.6M+21.0%
Net income$380.7M+6.3%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.66B+19.3%
Enterprise value$49.92B+22.2%
P/E47.1×+36.8×
P/S8.2×+0.4×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's EPS (diluted)?
Edwards Lifesciences (EW) reported EPS (diluted) of $0.66 in Q1 2026.
How has Edwards Lifesciences's EPS (diluted) changed year-over-year?
Edwards Lifesciences's EPS (diluted) increased by 8.2% year-over-year, from $0.61 to $0.66.
What is the long-term trend for Edwards Lifesciences's EPS (diluted)?
Over 4 years (2021 to 2025), Edwards Lifesciences's EPS (diluted) has grown at a -6.5% compound annual growth rate (CAGR), from $2.39 to $1.83.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.